MARCH MYELOMA ACTION MONTH Logo (WIPO, 08/08/2018)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark MARCH MYELOMA ACTION MONTH was filed as Figurative mark on 08/08/2018 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Plants, objects or geometrical figures representing a personage or an animal; masks or fantastic or unidentifiable heads #Letters presenting a special form of writing #Other unidentifiable personifications, other fantastic beings of human appearance, genies, snowmen, scarecrows and ghosts #Series of letters in different dimensions
| Trademark form | Figurative mark |
| File reference | 1430891 |
| Countries | 
|
| Base trademark |
No. 87799276,
February 15, 2018
|
| Application date | August 8, 2018 |
| Expiration date | August 8, 2028 |
Trademark owner
12650 Riverside Drive, Suite 206
North Hollywood CA 91607
US
North Hollywood CA 91607
US
Trademark representatives
1900 Avenue of the Stars,
Suite 2100
US
goods and services
35
Association services, namely, promoting the public interest
and awareness in cancer research and education (terms
considered too vague by the International Bureau – Rule 13
(2) (b) of the Common Regulations); association services,
namely, promoting public awareness of myeloma research,
diagnosis and treatment, and the need for access to a broad
range of approved and medically-accepted anticancer regimens
(terms considered too vague by the International Bureau – Rule 13 (2) (b) of the Common Regulations); promoting
awareness of the need for access to a broad range of
approved and medically-accepted anticancer regimens (terms
considered too vague by the International Bureau – Rule 13
(2) (b) of the Common Regulations); promoting collaboration
within the scientific, research and provider communities to
achieve advances in the field of myeloma research, diagnosis
and treatment (terms considered too vague by the
International Bureau – Rule 13 (2) (b) of the Common
Regulations); promoting public awareness of the need for
access to a broad range of approved and medically-accepted
anticancer regimen by means of public advocacy (terms
considered too vague by the International Bureau – Rule 13
(2) (b) of the Common Regulations)
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| November 7, 2019 | 2019/45 Gaz | JP | Rejection |
| March 27, 2019 | 2019/13 Gaz | EM | Rejection |
| August 8, 2018 | 2018/41 Gaz | US | Registration |
ID: 141430891